Cheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cheng Zhang has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Jing Ma
Department of Respiratory and Critical Care Medicine Peking University First Hospital Beijing China
10 shared publications - Guangfa Wang
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China
7 shared publications Yane Shen
Peking University First Hospital
4 shared publications- Jue Zhang
Academy for Advanced Interdisciplinary Studies, Peking University
3 shared publications Zhe Jin
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China
3 shared publicationsYunxia Wang
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China
2 shared publications
Latest Publications
- Open Access
- 28 January 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Efficacy of repeated self-guided digital cognitive behavioral therapy for chronic insomnia: A pilot open-label study following a previous RCT
Objective: This study aimed to assess whether a second course of digital cognitive behavioral therapy for insomnia (dCBT-I) could benefit patients with chronic insomnia who had suboptimal responses to the initial fully self-guided dCBT-I. Methods: Building on a previous randomized controlled trial (RCT), participants with an Insomnia Severity Index (ISI) score ≥8 at 6 months after completing the initial digital CBT-I therapy were invited to enroll in the second phase of the study. Among the 20 eligible participants, 9 received a second round of digital dCBT-I therapy, 6 participated in follow-up only. Primary outcomes included changes in ISI scores and ISI remission rates (defined as ISI p < 0.05). At the 3-month follow-up, the second treatment group showed a greater improvement in ISI scores (3.00(1.25, 5.00)) compared to the follow-up only group (−1.50(−3.25, 0.50)) ( p < 0.05). Conclusion: The present study suggests that a second course of digital CBT-I may benefit chronic insomnia patients who initially fail to achieve ISI remission after the first round of self-guided digital CBT-I. However, larger randomized controlled trials are needed to definitively assess its effectiveness.
- 28 January 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Open AccessEfficacy of repeated self-guided digital cognitive behavioral therapy for chronic insomnia: A pilot open-label study following a previous RCT
Objective: This study aimed to assess whether a second course of digital cognitive behavioral therapy for insomnia (dCBT-I) could benefit patients with chronic insomnia who had suboptimal responses to the initial fully self-guided dCBT-I. Methods: Building on a previous randomized controlled trial (RCT), participants with an Insomnia Severity Index (ISI) score ≥8 at 6 months after completing the initial digital CBT-I therapy were invited to enroll in the second phase of the study. Among the 20 eligible participants, 9 received a second round of digital dCBT-I therapy, 6 participated in follow-up only. Primary outcomes included changes in ISI scores and ISI remission rates (defined as ISI p < 0.05). At the 3-month follow-up, the second treatment group showed a greater improvement in ISI scores (3.00(1.25, 5.00)) compared to the follow-up only group (−1.50(−3.25, 0.50)) ( p < 0.05). Conclusion: The present study suggests that a second course of digital CBT-I may benefit chronic insomnia patients who initially fail to achieve ISI remission after the first round of self-guided digital CBT-I. However, larger randomized controlled trials are needed to definitively assess its effectiveness.
- 27 November 2025
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 102 (1207) , 446-453
Exploring the effect of a culturally adapted and personalized digital CBT-I app in insomnia patients with mild-to-moderate OSA: a secondary analysis of a randomized controlled trial
Background: This study aimed to evaluate the effectiveness of a culturally adapted, interactive, and personalized digital cognitive behavioral therapy (CBT-I) for individuals with co-morbid insomnia and sleep apnea (COMISA), and to compare the treatment outcomes with those of insomnia alone. Methods: This secondary analysis utilized data from a prior randomized controlled trial. The efficacy of digital CBT-I (dCBT-I) on insomnia severity and mental health was assessed in both COMISA and insomnia-only groups at postintervention and at 1-, 3-, and 6-month follow-ups. Results: Among 38 insomnia participants who completed the dCBT-I, 20 underwent sleep studies (4 males, 16 females; mean age 52.3 ± 13.0 years). Seven were diagnosed as mild-to-moderate obstructive sleep apnea (COMISA), and 13 did not (insomnia alone). Compared with baseline, the insomnia severity index scores significantly decreased at postintervention and the 1-, 3-, and 6-month follow-ups in both the COMISA and insomnia alone groups (P < .05), with large effect sizes (Cohen’s d > 1.0). No significant differences were observed between the two groups in insomnia severity index scores at baseline, postintervention, and at 1-, 3-, and 6-month follow-ups (P > .05). Mixed-effects models indicated no significant group × time interaction on insomnia severity index scores (P > .05). Wake time after sleep onset, sleep efficiency of the sleep diaries, and health questionnaire (PHQ-9) scores also improved significantly postintervention and at follow-up in both groups. Conclusions: This self-guided, culturally adapted, and personalized dCBT-I effectively improved insomnia severity, sleep quality, and depressive symptoms among individuals with COMISA. While treatment effects were comparable between COMISA and insomnia-alone groups, the observed numerical differences may reflect limited statistical power. Larger studies are warranted to determine whether individuals with comorbid obstructive sleep apnea respond differently to dCBT-I. Key messages What is already known on this topic: Cognitive behavioral therapy for insomnia may improve outcomes in patients with comorbid insomnia and sleep apnea. What this study adds: This study shows that an interactive, personalized, and culturally adapted digital cognitive behavioral therapy for insomnia program is also effective for comorbid insomnia and sleep apnea patients. How this study might affect research, practice, or policy: These findings support broader implementation of tailored digital cognitive behavioral therapy for insomnia in the treatment of comorbid insomnia and sleep apnea.
- 27 November 2025
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 102 (1207) , 446-453
Exploring the effect of a culturally adapted and personalized digital CBT-I app in insomnia patients with mild-to-moderate OSA: a secondary analysis of a randomized controlled trial
Background: This study aimed to evaluate the effectiveness of a culturally adapted, interactive, and personalized digital cognitive behavioral therapy (CBT-I) for individuals with co-morbid insomnia and sleep apnea (COMISA), and to compare the treatment outcomes with those of insomnia alone. Methods: This secondary analysis utilized data from a prior randomized controlled trial. The efficacy of digital CBT-I (dCBT-I) on insomnia severity and mental health was assessed in both COMISA and insomnia-only groups at postintervention and at 1-, 3-, and 6-month follow-ups. Results: Among 38 insomnia participants who completed the dCBT-I, 20 underwent sleep studies (4 males, 16 females; mean age 52.3 ± 13.0 years). Seven were diagnosed as mild-to-moderate obstructive sleep apnea (COMISA), and 13 did not (insomnia alone). Compared with baseline, the insomnia severity index scores significantly decreased at postintervention and the 1-, 3-, and 6-month follow-ups in both the COMISA and insomnia alone groups (P < .05), with large effect sizes (Cohen’s d > 1.0). No significant differences were observed between the two groups in insomnia severity index scores at baseline, postintervention, and at 1-, 3-, and 6-month follow-ups (P > .05). Mixed-effects models indicated no significant group × time interaction on insomnia severity index scores (P > .05). Wake time after sleep onset, sleep efficiency of the sleep diaries, and health questionnaire (PHQ-9) scores also improved significantly postintervention and at follow-up in both groups. Conclusions: This self-guided, culturally adapted, and personalized dCBT-I effectively improved insomnia severity, sleep quality, and depressive symptoms among individuals with COMISA. While treatment effects were comparable between COMISA and insomnia-alone groups, the observed numerical differences may reflect limited statistical power. Larger studies are warranted to determine whether individuals with comorbid obstructive sleep apnea respond differently to dCBT-I. Key messages What is already known on this topic: Cognitive behavioral therapy for insomnia may improve outcomes in patients with comorbid insomnia and sleep apnea. What this study adds: This study shows that an interactive, personalized, and culturally adapted digital cognitive behavioral therapy for insomnia program is also effective for comorbid insomnia and sleep apnea patients. How this study might affect research, practice, or policy: These findings support broader implementation of tailored digital cognitive behavioral therapy for insomnia in the treatment of comorbid insomnia and sleep apnea.
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (8) , 6339-6347
Relationship between shift scheduling, sleep knowledge and sleep quality in medical trainees: protocol for a global cross-sectional survey
Background: Although many studies suggest that shift work and nocturnal on-call rotations are associated with adverse outcomes in medical trainees’ health, evidence regarding the optimal frequency and duration of shifts that balance trainee well-being, patient safety, and medical education remains limited. Additionally, the level of medical trainees’ knowledge about sleep medicine and its possible relationship with their well-being during on-call periods remains unclear. Methods: This study protocol was designed in collaboration between professional sleep physicians from the USA, UK, Nigeria and France as a global multi-centred, cross-sectional, online survey conducted through a secure online link (REDCap 14.0.42, Vanderbilt University, USA). The proposed design covers demographic characteristics, different specialties, work conditions, on-call situations, sleep, mood, and social issues, as well as other relevant health factors. The methodology includes univariate, multivariate analyses, and regression models. The intended analysis aims to investigate the impact of on-call duties, as well as sleep knowledge, on the sleep quality and well-being of medical trainees. Discussion: Through this study, we expect to explore how different shift scheduling patterns and levels of sleep knowledge may be associated with the sleep quality of medical trainees. In addition, cross-cultural comparisons among diverse linguistic and cultural contexts will be examined. Trial Registration: The study is registered on ClinicalTrials.gov (NCT06706453).
- 1 August 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (8) , 6339-6347
Open AccessRelationship between shift scheduling, sleep knowledge and sleep quality in medical trainees: protocol for a global cross-sectional survey
Background: Although many studies suggest that shift work and nocturnal on-call rotations are associated with adverse outcomes in medical trainees’ health, evidence regarding the optimal frequency and duration of shifts that balance trainee well-being, patient safety, and medical education remains limited. Additionally, the level of medical trainees’ knowledge about sleep medicine and its possible relationship with their well-being during on-call periods remains unclear. Methods: This study protocol was designed in collaboration between professional sleep physicians from the USA, UK, Nigeria and France as a global multi-centred, cross-sectional, online survey conducted through a secure online link (REDCap 14.0.42, Vanderbilt University, USA). The proposed design covers demographic characteristics, different specialties, work conditions, on-call situations, sleep, mood, and social issues, as well as other relevant health factors. The methodology includes univariate, multivariate analyses, and regression models. The intended analysis aims to investigate the impact of on-call duties, as well as sleep knowledge, on the sleep quality and well-being of medical trainees. Discussion: Through this study, we expect to explore how different shift scheduling patterns and levels of sleep knowledge may be associated with the sleep quality of medical trainees. In addition, cross-cultural comparisons among diverse linguistic and cultural contexts will be examined. Trial Registration: The study is registered on ClinicalTrials.gov (NCT06706453).
- 2 January 2024
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 136 (1) , 30-35
Correlation of morning dry mouth with clinical features of OSA in a community population: a cross-sectional study
- 2 January 2024
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 136 (1) , 30-35
Correlation of morning dry mouth with clinical features of OSA in a community population: a cross-sectional study
- 27 February 2023
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 39 (4) , 621-626
Association between preserved ratio impaired spirometry and sleep apnea in a Chinese community
Psychosis in Parkinson’s disease includes hallucinations and delusions. Other non-psychotic neuropsychiatric features include depression, anxiety and apathy. There is currently controversy over whe...
- 27 February 2023
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 39 (4) , 621-626
Association between preserved ratio impaired spirometry and sleep apnea in a Chinese community
Psychosis in Parkinson’s disease includes hallucinations and delusions. Other non-psychotic neuropsychiatric features include depression, anxiety and apathy. There is currently controversy over whe...
- 2 November 2022
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 16 (11-12) , 1247-1256
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients
Obstructive sleep apnea (OSA) and hypertension are interrelated diseases linked to gut dysbiosis. This study aimed to investigate the effect of OSA on the gut microbiome in the context of hypertens...
- 2 November 2022
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 16 (11-12) , 1247-1256
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients
Obstructive sleep apnea (OSA) and hypertension are interrelated diseases linked to gut dysbiosis. This study aimed to investigate the effect of OSA on the gut microbiome in the context of hypertens...
- 15 March 2022
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 133 (9) , 1045-1054
Characteristics and feasibility of ambulatory respiratory assessment of paediatric neuromuscular disease: an observational retrospective study
To investigate the characteristics of respiratory involvement in Chinese paediatric neuromuscular disease (NMD) at early stage and to explore convenient monitoring methods.Children with NMD (age < ...
- 15 March 2022
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 133 (9) , 1045-1054
Characteristics and feasibility of ambulatory respiratory assessment of paediatric neuromuscular disease: an observational retrospective study
To investigate the characteristics of respiratory involvement in Chinese paediatric neuromuscular disease (NMD) at early stage and to explore convenient monitoring methods.Children with NMD (age < ...
- Open Access
- 22 April 2021
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2021, 1-6
Effects of Continuous Positive Airway Pressure on Sleep EEG Characteristics in Patients with Primary Central Sleep Apnea Syndrome
This study aimed to investigate the effects of continuous positive airway pressure (CPAP) on the electroencephalographic (EEG) characteristics of patients with primary central sleep apnea syndrome (CSAS). Nine patients with primary CSAS were enrolled in this study. The raw sleep EEG data were analyzed based on two main factors: fractal dimension (FD) and zero-crossing rate of detrended FD. Additionally, conventional EEG spectral analysis in the delta, theta, alpha, and beta bands was conducted using a fast Fourier transform. The FD in patients with primary CSAS who underwent CPAP treatment was significantly decreased during nonrapid eye movement (NREM) sleep but increased during rapid eye movement (REM) sleep ( ). Regarding the EEG spectral analysis, the alpha power increased, while the delta/alpha ratio decreased during REM sleep in patients with CSAS ( ). In conclusion, CPAP treatment can reduce FD in NREM sleep and increase FD during REM sleep in patients with primary CSAS. FD may be used as a new biomarker of EEG stability and improvement in brain function after CPAP treatment for primary CSAS.
- 22 April 2021
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2021, 1-6
Open AccessEffects of Continuous Positive Airway Pressure on Sleep EEG Characteristics in Patients with Primary Central Sleep Apnea Syndrome
This study aimed to investigate the effects of continuous positive airway pressure (CPAP) on the electroencephalographic (EEG) characteristics of patients with primary central sleep apnea syndrome (CSAS). Nine patients with primary CSAS were enrolled in this study. The raw sleep EEG data were analyzed based on two main factors: fractal dimension (FD) and zero-crossing rate of detrended FD. Additionally, conventional EEG spectral analysis in the delta, theta, alpha, and beta bands was conducted using a fast Fourier transform. The FD in patients with primary CSAS who underwent CPAP treatment was significantly decreased during nonrapid eye movement (NREM) sleep but increased during rapid eye movement (REM) sleep ( ). Regarding the EEG spectral analysis, the alpha power increased, while the delta/alpha ratio decreased during REM sleep in patients with CSAS ( ). In conclusion, CPAP treatment can reduce FD in NREM sleep and increase FD during REM sleep in patients with primary CSAS. FD may be used as a new biomarker of EEG stability and improvement in brain function after CPAP treatment for primary CSAS.
- 15 April 2021
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 133 (5) , 531-540
A community study of the risk for obstructive sleep apnea and respiratory inflammation in an adult Chinese population
Objectives: We aimed to investigate the relationship between obstructive sleep apnea (OSA) risk and respiratory inflammation evaluated by the exhaled breath condensate (EBC) interleukin-6 (IL-6) and plasma surfactant protein-D (SP-D), based on the Berlin questionnaire (BQ) screening values in an adult, urban community in Beijing, China. Methods: Volunteers aged >40 years were recruited from the Shichahai community of central Beijing (Registration number: NCT04832711). Their general information and disease history were recorded. OSA risk was assessed using the BQ. IL-6 in EBC and plasma SP-D were d etected by enzyme-linked immunoassay through specimens collected while fasting. The differences in IL-6 and SP-D values between high-risk and low-risk groups for OSA were compared, and the factors affecting their values were analyzed. Results: Among 1,239 participants, 18.8% of participants were in the high-risk group. There were more participants with higher body mass index, chronic hypertension, coronary heart disease, and diabetes in the high-risk group than in the low-risk group (P < 0.05). There were no significant differences in EBC IL-6 and plasma SP-D between the high- and low-OSA risk groups (p > 0.05). After adjustment for age, sex and chronic comorbidities, multivariate logistic regression showed that there was no correlation between risk of OSA and IL-6 in EBC. However, the risk of OSA (odds ratio [OR] [95% CI]: 1.69 [1.15,2.48]; β = 0.522) and BMI (OR [95%CI]: 0.94 [0.91,0.98]; β = −0.061) were independently associated with plasma SP-D level (p < 0.05 for both). Stratification analysis showed that OSA risk were independently associated with plasma SP-D levels in participants <65 years, or men, or participants with BMI<25. Conclusion: This study showed that plasma SP-D, an inflammation biomarker, was associated with risk of OSA and BMI in a Chinese central urban community. The relationship between the risk of OSA and respiratory inflammation in community populations needs to be further evaluated.
- 15 April 2021
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 133 (5) , 531-540
A community study of the risk for obstructive sleep apnea and respiratory inflammation in an adult Chinese population
Objectives: We aimed to investigate the relationship between obstructive sleep apnea (OSA) risk and respiratory inflammation evaluated by the exhaled breath condensate (EBC) interleukin-6 (IL-6) and plasma surfactant protein-D (SP-D), based on the Berlin questionnaire (BQ) screening values in an adult, urban community in Beijing, China. Methods: Volunteers aged >40 years were recruited from the Shichahai community of central Beijing (Registration number: NCT04832711). Their general information and disease history were recorded. OSA risk was assessed using the BQ. IL-6 in EBC and plasma SP-D were d etected by enzyme-linked immunoassay through specimens collected while fasting. The differences in IL-6 and SP-D values between high-risk and low-risk groups for OSA were compared, and the factors affecting their values were analyzed. Results: Among 1,239 participants, 18.8% of participants were in the high-risk group. There were more participants with higher body mass index, chronic hypertension, coronary heart disease, and diabetes in the high-risk group than in the low-risk group (P < 0.05). There were no significant differences in EBC IL-6 and plasma SP-D between the high- and low-OSA risk groups (p > 0.05). After adjustment for age, sex and chronic comorbidities, multivariate logistic regression showed that there was no correlation between risk of OSA and IL-6 in EBC. However, the risk of OSA (odds ratio [OR] [95% CI]: 1.69 [1.15,2.48]; β = 0.522) and BMI (OR [95%CI]: 0.94 [0.91,0.98]; β = −0.061) were independently associated with plasma SP-D level (p < 0.05 for both). Stratification analysis showed that OSA risk were independently associated with plasma SP-D levels in participants <65 years, or men, or participants with BMI<25. Conclusion: This study showed that plasma SP-D, an inflammation biomarker, was associated with risk of OSA and BMI in a Chinese central urban community. The relationship between the risk of OSA and respiratory inflammation in community populations needs to be further evaluated.
- RetractedOpen Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
[Retracted] NREM Sleep EEG Characteristics Correlate to the Mild Cognitive Impairment in Patients with Parkinsonism
Early identification and diagnosis of mild cognitive impairment (MCI) in patients with parkinsonism (PDS) are critical. The aim of this study was to identify biomarkers of MCI in PDS using conventional electroencephalogram (EEG) power spectral analysis and detrended fluctuation analysis (DFA). In this retrospective study, patients with PDS who underwent an overnight polysomnography (PSG) study in our hospital from 2019 to 2020 were enrolled. Patients with PDS assessed by clinical examination and questionnaires were divided into two groups: the PDS with normal cognitive function (PDS‐NC) group and the PDS with MCI (PDS‐MCI) group. Sleep EEG signals were extracted and purified from the PSG and subjected to a conventional power spectral analysis, as well as detrended fluctuation analysis (DFA) during wakefulness, nonrapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep. Forty patients with PDS were enrolled, including 25 with PDS‐NC and 15 with PDS‐MCI. Results revealed that compared with PDS‐NC patients, patients with PDS‐MCI had a reduced fast ratio ((alpha + beta)/(delta + theta)) and increased DFA during NREM sleep. DFA during NREM was diagnostic of PDS‐MCI, with an area under the receiver operating characteristic curve of 0.753 (95% CI: 0.592–0.914) (p < 0.05). Mild cognitive dysfunction was positively correlated with NREM‐DFA (r = 0.426, p = 0.007) and negatively correlated with an NREM‐fast ratio (r = −0.524, p = 0.001). This suggested that altered EEG activity during NREM sleep is associated with MCI in patients with PDS. NREM sleep EEG characteristics of the power spectral analysis and DFA correlate to MCI. Slowing of EEG activity during NREM sleep may reflect contribution to the decline in NREM physiological function and is therefore a marker in patients with PDS‐MCI.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
RetractedOpen Access[Retracted] NREM Sleep EEG Characteristics Correlate to the Mild Cognitive Impairment in Patients with Parkinsonism
Early identification and diagnosis of mild cognitive impairment (MCI) in patients with parkinsonism (PDS) are critical. The aim of this study was to identify biomarkers of MCI in PDS using conventional electroencephalogram (EEG) power spectral analysis and detrended fluctuation analysis (DFA). In this retrospective study, patients with PDS who underwent an overnight polysomnography (PSG) study in our hospital from 2019 to 2020 were enrolled. Patients with PDS assessed by clinical examination and questionnaires were divided into two groups: the PDS with normal cognitive function (PDS‐NC) group and the PDS with MCI (PDS‐MCI) group. Sleep EEG signals were extracted and purified from the PSG and subjected to a conventional power spectral analysis, as well as detrended fluctuation analysis (DFA) during wakefulness, nonrapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep. Forty patients with PDS were enrolled, including 25 with PDS‐NC and 15 with PDS‐MCI. Results revealed that compared with PDS‐NC patients, patients with PDS‐MCI had a reduced fast ratio ((alpha + beta)/(delta + theta)) and increased DFA during NREM sleep. DFA during NREM was diagnostic of PDS‐MCI, with an area under the receiver operating characteristic curve of 0.753 (95% CI: 0.592–0.914) (p < 0.05). Mild cognitive dysfunction was positively correlated with NREM‐DFA (r = 0.426, p = 0.007) and negatively correlated with an NREM‐fast ratio (r = −0.524, p = 0.001). This suggested that altered EEG activity during NREM sleep is associated with MCI in patients with PDS. NREM sleep EEG characteristics of the power spectral analysis and DFA correlate to MCI. Slowing of EEG activity during NREM sleep may reflect contribution to the decline in NREM physiological function and is therefore a marker in patients with PDS‐MCI.